Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause.

Next Previous
Search
Trial Profile

Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause.

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol (Primary) ; Progesterone
  • Indications Cardiovascular disorders; Depression; Depressive disorders; Menopausal syndrome
  • Focus Therapeutic Use
  • Acronyms PERT

Most Recent Events

  • 10 Jan 2018 Primary endpoint (Change in Depressive Symptoms as Indicated by The Center for Epidemiologic Studies Depression Scale (CES-D)) has been met, according to Results published in the JAMA Psychiatry Journal.
  • 10 Jan 2018 Results published in the JAMA Psychiatry Journal.
  • 06 Apr 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top